ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,824Medicare Part D Prescriptions Filled, Including Refills

Rank: 58 out of 1448

$803K Total Retail Price of All Prescriptions

Rank: 51 out of 1448

251 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 251 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

0% of this provider’s 10,425 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

43% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
ISOSORBIDE MONONITRATE ER 549 542 1 16
AMLODIPINE BESYLATE 458 434 2 2
CARVEDILOL 373 361 3 1
METFORMIN HCL 345 335 4 25
SIMVASTATIN 333 327 5 3
METOPROLOL SUCCINATE 319 312 6 6
CLOPIDOGREL 314 299 7 10
AMIODARONE HCL 272 243 8 22
DIOVAN 237 235 9 15
PLAVIX 214 211 10 14
ALENDRONATE SODIUM 198 198 11 41
OMEPRAZOLE 197 185 12 23
LOVAZA 195 195 13 39
CREON 192 192 14 168
DIOVAN HCT 187 187 15 29
MELOXICAM 180 177 16 73
CRESTOR 165 152 17 17
LIDODERM 158 158 18 81
DIGOXIN 144 144 19 13
NEXIUM 139 139 20 49
ALLOPURINOL 136 118 21 43
LOSARTAN POTASSIUM 134 123 22 11
ATORVASTATIN CALCIUM 130 129 23 4
NIASPAN 117 103 24 47
ZOLPIDEM TARTRATE 115 112 25 34
EVISTA 115 115 25 134
DOXAZOSIN MESYLATE 115 115 25 65
COREG CR 110 110 28 83
GABAPENTIN 110 109 28 51
TAMSULOSIN HCL 107 107 30 46
LEVOTHYROXINE SODIUM 106 106 31 21
RANEXA 103 103 32 37
CELEBREX 102 97 33 77
DONEPEZIL HCL 99 99 34 68
JANUVIA 99 99 34 64
PANTOPRAZOLE SODIUM 93 92 36 42
LOSARTAN-HYDROCHLOROTHIAZIDE 89 75 37 38
ALBUTEROL SULFATE 88 88 38 194
WARFARIN SODIUM 87 87 39 8
ACTONEL 86 83 40 117
ADVAIR DISKUS 85 84 41 74
PRAVASTATIN SODIUM 77 72 42 20
GLIMEPIRIDE 77 77 42 66
FAMOTIDINE 69 69 44 60
GLIPIZIDE 65 50 45 75
AZOR 63 53 46 125
CLONIDINE HCL 63 61 46 45
FENOFIBRATE 63 63 46 54
ZETIA 62 62 49 28
TRICOR 61 60 50 94
TRIAMCINOLONE ACETONIDE 60 60 51 96
AMLODIPINE BESYLATE-BENAZEPRIL 60 60 51 67
GEMFIBROZIL 59 55 53 127
FUROSEMIDE 58 54 54 7
ATENOLOL 58 58 54 12
EXFORGE 57 52 56 80
TEKTURNA 54 54 57 106
NAMENDA 53 53 58 93
NITROGLYCERIN PATCH 52 51 59 98
AVODART 50 49 60 120
AZITHROMYCIN 50 50 60 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.